Risk of metastasis and survival in patients undergoing different treatment strategies with T1 colonic neuroendocrine tumors

被引:1
作者
Wu, X. [1 ]
Peng, C. [1 ]
Lin, M. [1 ]
Li, Z. [1 ,2 ]
Yang, X. [1 ,2 ,3 ]
Liu, J. [1 ]
Zuo, X. [1 ,2 ,4 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Gastroenterol, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Lab Translat Gastroenterol, Jinan, Shandong, Peoples R China
[3] Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan, Shandong, Peoples R China
[4] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Robot Engn Lab Precise Diag & Therapy GI Tumor, Jinan, Shandong, Peoples R China
关键词
Colonic neuroendocrine tumors; Metastasis risk; SEER; Survival; Treatment strategies; CARCINOID-TUMORS; RECTAL NEUROENDOCRINE; CONSENSUS GUIDELINES; DIAGNOSIS; EPIDEMIOLOGY; MANAGEMENT; SIZE;
D O I
10.1007/s40618-023-02185-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
\Purpose The efficacy and safety of local excision (LE) for small (< 1-2 cm) colonic neuroendocrine tumors (NETs) is controversial due to the higher metastasis risk when compared with rectal NETs. The study aimed to evaluate the metastasis risk of T1 colonic NETs and compare patients' long-term prognosis after LE or radical surgery (RS). Methods The Surveillance Epidemiology and End Results database was used to identify patients with T1 colonic NETs (2004.2015). Multivariable logistic regression was performed to assess factors associated with metastasis risk. Propensity score matching was used to balance the variables. Cancer-specific survival (CSS) and overall survival (OS) were calculated to estimate the prognosis of patients with T1N0M0 colonic NETs who underwent LE or RS. Results Of the 610 patients with colonic NETs, 46 (7.54%) had metastasis at diagnosis. Tumor size (11-20 mm) (OR = 9.51; 95% confidence interval (CI): 4.32.21.45; P < 0.001), right colon (OR = 15.79; 95% CI 7.20.38.56; P < 0.001), submucosal infiltration (OR = 2.08; 95% CI 0.84.5.57; P = 0.125) were independent risk factors associated with metastasis. Of the 515 patients with T1N0M0 colonic NETs, the overall long-term prognosis of LE was as good as that of RS groups (after matching, 5-year CSS: 97.9% vs. 94.6%, P = 0.450; 5-year OS: 92.7% vs. 85.6%, P = 0.009). Conclusion Tumor size (11.20 mm) and site (right colon) are associated with metastasis in T1 colonic NETs. In the absence of metastasis, LE could be a viable option for 0.10 mm T1 colonic NETs with well/moderate differentiation in the left colon in terms of long-term survival.
引用
收藏
页码:671 / 681
页数:11
相关论文
共 50 条
  • [41] Tumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: a retrospective study
    Kye, Bong-Hyeon
    Jung, Ji-Han
    Kim, Hyung-Jin
    Kang, Se-Goo
    Cho, Hyeon-Min
    Kim, Jun-Gi
    BMC SURGERY, 2012, 12
  • [42] Risk of metastasis among patients diagnosed with high-risk T1 esophageal adenocarcinoma who underwent endoscopic follow-up
    Norton, Benjamin Charles
    Aslam, Nasar
    Telese, Andrea
    Papaefthymiou, Apostolis
    Singh, Shilpi
    Sehgal, Vinay
    Mitchison, Miriam
    Jansen, Marnix
    Banks, Matthew
    Graham, David
    Haidry, Rehan
    DISEASES OF THE ESOPHAGUS, 2024, 37 (08)
  • [43] Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma
    Nakadoi, Koichi
    Oka, Shiro
    Tanaka, Shinji
    Hayashi, Nana
    Terasaki, Motomi
    Arihiro, Koji
    Shimamoto, Fumio
    Chayama, Kazuaki
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2014, 28 (04): : 1269 - 1276
  • [44] CT morphological features for predicting the risk of lymph node metastasis in T1 colorectal cancer
    Li, Suyun
    Li, Zhenhui
    Wang, Li
    Wu, Mimi
    Chen, Xiaobo
    He, Chutong
    Xu, Yao
    Dong, Mengyi
    Liang, Yanting
    Chen, Xin
    Liu, Zaiyi
    EUROPEAN RADIOLOGY, 2023, 33 (10) : 6861 - 6871
  • [45] Tumor Necrosis Impacts Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma
    Tsilimigras, Diamantis, I
    Ejaz, Aslam
    Cloyd, Jordan
    Guglielmi, Alfredo
    Aldrighetti, Luca
    Weiss, Matthew
    Bauer, Todd W.
    Alexandrescu, Sorin
    Poultsides, George A.
    Maithel, Shishir K.
    Marques, Hugo P.
    Martel, Guillaume
    Pulitano, Carlo
    Shen, Feng
    Soubrane, Olivier
    Koerkamp, Bas Groot
    Endo, Itaru
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4326 - 4334
  • [46] Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study
    Mo, Xiaofei
    Zhou, Mingge
    Yan, Hui
    Chen, Xueqin
    Wang, Yuetao
    CANCER MEDICINE, 2021, 10 (15): : 5338 - 5346
  • [47] Low Galectin-3 Expression Level in Primary Tumors Is Associated with Metastasis in T1 Lung Adenocarcinoma
    Kao, Ming-Wei
    Su, Yue-Chiu
    Liang, Peir-In
    Wu, Yi-Ying
    Hong, Tse-Ming
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 11
  • [48] Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis
    Jiang, Kai-Yuan
    Huang, Heng
    Chen, Wei-Yang
    Yan, Hao-Ji
    Wei, Zhen-Ting
    Wang, Xiao-Wen
    Li, Hao-Xuan
    Zheng, Xiang-Yun
    Tian, Dong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (08) : 737 - 750
  • [49] Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study
    Zhang, Tao
    Zhang, Jia-Tao
    Li, Wen-Feng
    Lin, Jun-Tao
    Liu, Si-Yang
    Yan, Hong-Hong
    Yang, Jin-Ji
    Yang, Xue-Ning
    Wu, Yi-Long
    Nie, Qiang
    Zhong, Wen-Zhao
    JOURNAL OF THORACIC DISEASE, 2019, 11 (07) : 2754 - 2762
  • [50] Factors Associated With Risk for Colorectal Cancer Recurrence After Endoscopic Resection of T1 Tumors
    Yoshii, Shinji
    Nojima, Masanori
    Nosho, Katsuhiko
    Omori, Saori
    Kusumi, Takaya
    Okuda, Hiroyuki
    Tsukagoshi, Hiroyuki
    Fujita, Masahiro
    Yamamoto, Hiroyuki
    Hosokawa, Masao
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (02) : 292 - +